Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Long-Term Debt Issuances: 2010-2011

  • Sonoma Pharmaceuticals' Long-Term Debt Issuances changed negligibly% to $1.0 million in Q4 2011 from the same period last year, while for Dec 2011 it was $5.5 million, marking a year-over-year change of. This contributed to the annual value of -$324,000 for FY2019, which is 145.45% down from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Long-Term Debt Issuances of $1.0 million as of Q4 2011, which was down 33.33% from $1.5 million recorded in Q2 2011.
  • Sonoma Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $2.0 million during Q2 2010, with a 5-year trough of $1.0 million in Q4 2010.
  • In the last 2 years, Sonoma Pharmaceuticals' Long-Term Debt Issuances had a median value of $1.2 million in 2010 and averaged $1.4 million.
  • Data for Sonoma Pharmaceuticals' Long-Term Debt Issuances shows a maximum YoY decreased of 25.00% (in 2011) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Long-Term Debt Issuances (Quarterly) stood at $1.0 million in 2010, then remained steady at $1.0 million in 2011.
  • Its Long-Term Debt Issuances stands at $1.0 million for Q4 2011, versus $1.5 million for Q2 2011 and $1.0 million for Q4 2010.